WallStreetZenWallStreetZen

NASDAQ: XFOR
X4 Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for XFOR

Based on 2 analysts offering 12 month price targets for X4 Pharmaceuticals Inc.
Min Forecast
$1.00-18.7%
Avg Forecast
$2.00+62.6%
Max Forecast
$3.00+143.9%

Should I buy or sell XFOR stock?

Based on 2 analysts offering ratings for X4 Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XFOR stock forecasts and price targets.

XFOR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2023-12-12

1 of 1

Forecast return on equity

Is XFOR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is XFOR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

XFOR revenue forecast

What is XFOR's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$32.8M
Avg 2 year Forecast
$64.8M
Avg 3 year Forecast
$116.6M

XFOR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
XFOR$1.23$2.00+62.60%Buy
DSGN$3.66$4.50+22.95%Hold
PSTX$2.16$15.00+594.44%Strong Buy
ATNM$6.96$29.25+320.26%Strong Buy
CMPX$1.52$9.00+492.11%Buy
View Top Biotech Stocks

X4 Pharmaceuticals Stock Forecast FAQ

Is X4 Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: XFOR) stock is to Buy XFOR stock.

Out of 2 analysts, 0 (0%) are recommending XFOR as a Strong Buy, 1 (50%) are recommending XFOR as a Buy, 1 (50%) are recommending XFOR as a Hold, 0 (0%) are recommending XFOR as a Sell, and 0 (0%) are recommending XFOR as a Strong Sell.

If you're new to stock investing, here's how to buy X4 Pharmaceuticals stock.

What is XFOR's revenue growth forecast for 2024-2026?

(NASDAQ: XFOR) X4 Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

X4 Pharmaceuticals's revenue in 2024 is $0.On average, 6 Wall Street analysts forecast XFOR's revenue for 2024 to be $5,511,885,910, with the lowest XFOR revenue forecast at $231,754,138, and the highest XFOR revenue forecast at $19,462,309,440. On average, 6 Wall Street analysts forecast XFOR's revenue for 2025 to be $10,873,971,320, with the lowest XFOR revenue forecast at $717,094,325, and the highest XFOR revenue forecast at $27,390,652,081.

In 2026, XFOR is forecast to generate $19,573,820,127 in revenue, with the lowest revenue forecast at $2,337,693,912 and the highest revenue forecast at $49,306,532,502.

What is XFOR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: XFOR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is XFOR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year XFOR price target, the average XFOR price target is $2.00, with the highest XFOR stock price forecast at $3.00 and the lowest XFOR stock price forecast at $1.00.

On average, Wall Street analysts predict that X4 Pharmaceuticals's share price could reach $2.00 by Mar 22, 2025. The average X4 Pharmaceuticals stock price prediction forecasts a potential upside of 62.6% from the current XFOR share price of $1.23.

What is XFOR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: XFOR) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.